Innovative Health Care: Digital Early Detection
Specializing in clinical signal processing and early detection of cardiac conditions through high frequency QRS analysis of ECG, and an innovative platform for advanced ECG analysis of any wearable recording device
to discuss opportunities
BSP Medical is a ground-breaking biomedical technology company, revolutionizing non-invasive diagnosis of cardiac diseases, through our FDA cleared and CE marked HyperQ technology and through the whole new wearable technology for home use and for medical experts use.
The company was founded by seasoned researchers in the field of high frequency ECG analysis. We are devoted to the HyperQ technology and promoting its clinical implementation in an effort to provide superior patient care.
We are a wholly owned subsidiary of ICB, Israel China Biotechnology Investments Ltd. which is publicly traded on the Tel Aviv Stock Exchange.
We are looking for business collaborations on our wearable and implantable R&D projects. Don’t hesitate to contact us by filling out this form or emailing us at Andrew@bsp.co.il to discuss opportunities.